Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
608202 Disclosed is an ophthalmic solution for the treatment of dry eye comprising 3% (w/v) of P1,P4-bis(5&rsquo-uridyl)tetraphosphate and 0.1 to 0.5% (w/v) of hyaluronic acid or a salt thereof. Also disclosed is the use of this combination in the manufacture of an agent for the treatment of dry eye.